A Study of RGT001-075 in Participants With Obesity or Overweight With Weight-Related Comorbidities
Public ClinicalTrials.gov record NCT06277934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of RGT001-075 Compared With Placebo in Adult Patients With Obesity or Overweight With Weight-Related Comorbidities
Study identification
- NCT ID
- NCT06277934
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Regor Pharmaceuticals Inc.
- Industry
- Enrollment
- 73 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- RGT001-075 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 7, 2024
- Primary completion
- Aug 12, 2024
- Completion
- Aug 12, 2024
- Last update posted
- Aug 6, 2025
2024
United States locations
- U.S. sites
- 10
- U.S. states
- 10
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Velocity Clinical Research | Los Angeles | California | 90057 | — |
| Velocity Clinical Research | Valparaiso | Indiana | 46383 | — |
| Velocity Clinical Research | Omaha | Nebraska | 68134 | — |
| Velocity Clinical Research | Vestal | New York | 13850 | — |
| Velocity Clinical Research | Durham | North Carolina | 27701 | — |
| Velocity Clinical Research | Cleveland | Ohio | 44122 | — |
| Velocity Clinical Research | Medford | Oregon | 97504 | — |
| Velocity Clinical Research | East Greenwich | Rhode Island | 02818 | — |
| Velocity Clinical Research | Dallas | Texas | 75230 | — |
| Velocity Clinical Research | West Jordan | Utah | 84088 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06277934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 6, 2025 · Synced Apr 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06277934 live on ClinicalTrials.gov.